Comments
Loading...

Altimmune

ALTNASDAQ
Logo brought to you by Benzinga Data
$7.43
-0.14-1.85%
At Close: -
$7.51
0.081.08%
After Hours: 7:53 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$35.00
Lowest Price Target1
$12.00
Consensus Price Target1
$22.00

Altimmune (NASDAQ:ALT) Stock, Analyst Ratings, Price Targets, Forecasts

Altimmune Inc has a consensus price target of $22 based on the ratings of 8 analysts. The high is $35 issued by Jefferies on August 31, 2022. The low is $12 issued by HC Wainwright & Co. on August 22, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., B. Riley Securities, and B. Riley Securities on August 22, 2024, August 12, 2024, and June 25, 2024, respectively. With an average price target of $17.33 between HC Wainwright & Co., B. Riley Securities, and B. Riley Securities, there's an implied 130.80% upside for Altimmune Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Mar
1
Apr
0
0
0
0
May
1
Jun
0
0
0
0
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
B. Riley Securities
Piper Sandler
JMP Securities
Goldman Sachs

1calculated from analyst ratings

Analyst Ratings for Altimmune

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Altimmune (ALT) stock?

A

The latest price target for Altimmune (NASDAQ:ALT) was reported by HC Wainwright & Co. on August 22, 2024. The analyst firm set a price target for $12.00 expecting ALT to rise to within 12 months (a possible 59.79% upside). 13 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Altimmune (ALT)?

A

The latest analyst rating for Altimmune (NASDAQ:ALT) was provided by HC Wainwright & Co., and Altimmune reiterated their buy rating.

Q

When was the last upgrade for Altimmune (ALT)?

A

There is no last upgrade for Altimmune

Q

When was the last downgrade for Altimmune (ALT)?

A

The last downgrade for Altimmune Inc happened on April 29, 2024 when Guggenheim changed their price target from N/A to N/A for Altimmune Inc.

Q

When is the next analyst rating going to be posted or updated for Altimmune (ALT)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Altimmune, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Altimmune was filed on August 22, 2024 so you should expect the next rating to be made available sometime around August 22, 2025.

Q

Is the Analyst Rating Altimmune (ALT) correct?

A

While ratings are subjective and will change, the latest Altimmune (ALT) rating was a reiterated with a price target of $12.00 to $12.00. The current price Altimmune (ALT) is trading at is $7.51, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch